Rare Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are at or above the legal age of consent in your country
- You have been newly diagnosed or have a returning (recurrent) primary brain tumour that falls into one of 17 specific tumour types being studied in this trial
- A stored tissue sample from your brain tumour surgery is available at the trial site (a sample from your first surgery is preferred, but a sample from surgery for a recurrence may also be accepted — except for one specific group in the trial, called Cohort 16, where only tissue from the first surgery is accepted)
- Brain scan images (MRI or CT) taken at the time of your original diagnosis are available
- You are willing and able to give your consent to take part
For deceased patients (where a loved one's data may be used):
- The patient previously agreed during their lifetime to allow their data, tissue, or scans to be used for research, OR a relative has given consent for this use, OR there is a legal basis that covers situations where getting consent is not possible or would cause undue difficulty
- There is no record that the patient ever objected to their data or samples being used for research
- An ethics committee has been notified about the use of the data, tissue, or scans
- Any additional legal requirements in the relevant country have been met
Who may not be able to join:
- Anyone who does not have a stored tumour tissue sample available at the trial site
- Anyone whose brain tumour type does not fall within the 17 specific groups being studied (confirm with trial site)
- Deceased patients whose data or samples cannot meet the legal and ethical requirements listed above
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Michael Weller, EORTC Study Coordinator
Phone: +32 2 774 1611
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Best overall and objective response; Progression free survival; Overall Survival; Patient and Disease Characteristics
Can't join this trial?
Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.